At a glance
European Partnership on Personalised Medicine is an EU-level competitive grant from European Commission for the horizon europe sector. Funding is up to €37M. Eligible applicants: Open to eligible organisations in EU Member States and Horizon Europe associated countries; consortium requirements vary by topic - see the official call conditions. The application deadline is January 20, 2027. Apply via the official listing at ec.europa.eu.
- Amount
- Up to €37M
- Deadline
- 20 Jan 2027
- Type
- Competitive
- Status
- Open
About this program
With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapies (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM.At least one of the following approaches must be employed:Somatic cell therapeutics;Gene therapeutics;Combined cell- and gene therapeutics;Novel biological products.For the entire scope, please consult the Call Text: https://www.eppermed.eu/funding-projects/calls/jtc2027/.
Who can apply
Open to eligible organisations in EU Member States and Horizon Europe associated countries; consortium requirements vary by topic - see the official call conditions.
How to apply
Apply through the EU Funding & Tenders portal; submission is electronic via the portal's Submission Service before the topic deadline.
Apply at official sourceRelated grants
- European network for upscaling venture builders’ roles in research performing organisations (CSA) EC · See listing · 2 Feb 2027 Open
- European Startup and Scaleup Hubs pilot EC · See listing · 5 Jan 2027 Open
- Demonstrating place-based experimentation and innovation spaces as enabling environments for scaling EU Missions EC · See listing · 13 Jan 2027 Open
- Valorising Horizon project results via innovation ecosystems EC · See listing · 16 Feb 2027 Open